Clinical and Patient-Reported Outcome Measures of Palatal Donor Site Healing Using Polyvinylpyrrolidone-Sodium Hyaluronate Gel as a Dressing Material Following Free Gingival Graft Harvesting: A Randomized Controlled Clinical Trial
- PMID: 39529394
- PMCID: PMC11554855
- DOI: 10.1002/cre2.70026
Clinical and Patient-Reported Outcome Measures of Palatal Donor Site Healing Using Polyvinylpyrrolidone-Sodium Hyaluronate Gel as a Dressing Material Following Free Gingival Graft Harvesting: A Randomized Controlled Clinical Trial
Abstract
Objectives: This study evaluates the efficacy of polyvinylpyrrolidone-sodium hyaluronate (PVP-SH) gel as a dressing material in enhancing both clinical and patient-reported outcomes post-free gingival graft (FGG) harvesting from the hard palate.
Material and methods: This randomized clinical trial included 18 patients and spanned from June 2022 to August 2023. Patients received an FGG procedure to manage a lack of attached gingiva. Following graft harvesting, patients were divided into two groups: the control group, which received Coe-Pak, and the test group, which was treated with PVP-SH gel. The primary outcome measured was complete epithelialization. Secondary outcomes included the Landry healing scale, post-operative pain level, and patient willingness to receive the same treatment again.
Results: The test group reported significantly lower analgesic use (p < 0.001) and reduced pain severity (p < 0.001) compared to the control group. Furthermore, test group patients indicated a higher level of satisfaction regarding the prospect of retreatment. In contrast, the control group showed significantly slower progress in wound healing and epithelization (p < 0.05) compared to the test group.
Conclusions: The findings of this study suggest that PVP-SH gel is a superior dressing material post-FGG harvesting, yielding improved clinical and patient-reported outcomes relative to Coe-Pak.
Keywords: pain; palate; wound healing.
© 2024 The Author(s). Clinical and Experimental Dental Research published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Barber, C. , Powell R., Ellis A., and Hewett J.. 2007. “Comparing Pain Control and Ability to Eat and Drink With Standard Therapy vs Gelclair: A Preliminary, Double Centre, Randomised Controlled Trial on Patients With Radiotherapy–Induced Oral Mucositis.” Supportive Care in Cancer 15: 427–440. - PubMed
-
- Basma, H. S. , Saleh M. H. A., Abou‐Arraj R. V., et al. 2023. “Patient‐Reported Outcomes of Palatal Donor Site Healing Using Four Different Wound Dressing Modalities Following Free Epithelialized Mucosal Grafts: A Four‐Arm Randomized Controlled Clinical Trial.” Journal of Periodontology 94, no. 1: 88–97. - PMC - PubMed
-
- Berndtson, M. 2001. “Preliminary Study of Orassist (Gelclair) in the Management of Oral Mucositis.” Swed Hosp Dent 26, no. 1: 17–21.
-
- Buchsel, P. C. 2008. “Polyvinylpyrrolidone–Sodium Hyaluronate Gel (Gelclair®): A Bioadherent Oral Gel for the Treatment of Oral Mucositis and Other Painful Oral Lesions.” Expert Opinion on Drug Metabolism & Toxicology 4, no. 11: 1449–1454. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous